Company Profile

ABBOTT INDIA LTD.

NSE : ABBOTINDIABSE : 500488ISIN CODE : INE358A01014Industry : Pharmaceuticals & DrugsHouse : Abbott India - MNC
BSE19086.15895.75 (+4.92 % )
PREV CLOSE (Rs.) 18190.40
OPEN PRICE (Rs.) 18100.05
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 1709
TODAY'S LOW / HIGH (Rs.)18068.80 19235.00
52 WK LOW / HIGH (Rs.)13970.1 19235
NSE19012.75 818.8 (+4.5 % )
PREV CLOSE(Rs.) 18193.95
OPEN PRICE (Rs.) 18190.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 19012.75 (74 )
VOLUME 24423
TODAY'S LOW / HIGH(Rs.) 18049.95 19244.70
52 WK LOW / HIGH (Rs.)13959.8 19244.7

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 1.44
TTM EPS (Rs.) 325.04
P/E Ratio 58.72
Book Value (Rs.) 1203.75
Face Value (Rs.) 10
MCap (Rs. in Mn) 405567.37
Price/Earning (TTM) 54.16
Price/Sales (TTM) 9.41
Price/Book (MRQ) 15.86
PAT Margin (%) 16.03
ROCE (%) 37.52
Incorporation Year : 1944

Management Info :

Munir Shaikh - Chairman Anil Joseph - Managing Director

Registered Office :

Address : Unit No. 3,Corporate Park,Sion Trombay Road,
Mumbai,
Maharashtra-400071

Phone : 022-50461000/2000/1119/1117/1116/6797 8888

Website : www.abbott.co.in

Registrar's Details : K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS More
13Jul07-13-2021$Abbott surges on launching COVID-19 home test kit in India Abbott surges on launching C

Abbott India is currently trading at Rs. 17388.20, up by 99.05 points or 0.57% from its previous closing of Rs. 17289.15 on the BSE.

The scrip opened at Rs. 17337.85 and has touched a high and low of Rs. 17388.20 and Rs. 17225.05 respectively.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 17500.00 on 12-Jul-2021 and a 52 week low of Rs. 13970.10 on 02-Feb-2021.

Last one week high and low of the scrip stood at Rs. 17500.00 and Rs. 16780.00 respectively. The current market cap of the company is Rs. 36657.38 crore.

The promoters holding in the company stood at 74.99%, while Institutions and Non-Institutions held 6.54% and 18.47% respectively.

Abbott has launched COVID-19 home test kit in India for the detection of the SARS-CoV-2 virus in adults and children with or without symptoms at a price of Rs 325 for a single test kit pack.

The company will deliver millions of Panbio COVID-19 rapid antigen tests, available for self-use, to ease the burden on healthcare systems in urban and rural India.

Abbott India is healthcare company that discovers, develops, manufactures and markets innovative products and services.

Abbott India is currently trading at Rs. 17388.20, up by 99.05..
13Jul07-13-2021$M&M, Ashoka Buildcon and FDC to see some action today M&M, Ashoka Buildcon and FDC

Mahindra & Mahindra (M&M) has increased the prices of all the models. This is the third time that the Indian car manufacturer has raised its prices this year as previously a price correction was introduced in January, followed by May. Prices for the Mahindra Thar have gone up by around Rs 42,300 to Rs 1,02,000, depending on the variant. This translates to about 2-7 per cent hike, the highest for any model with this round of price hike. The SUV has gotten expensive by approximately nearly Rs 1 lakh. The AX variant of the SUV is expensive by Rs 67,000.

Ashoka Buildcon has received Letter of Acceptance (LoA) from National Highways Authority of India (NHAI) in respect of the Project viz. 'Request for Proposal for Development of Memmadpur (Ambala) - Banur (IT City Chowk) - Kharar (Chandigarh) Corridor under Bharatmala Pariyojana - Package-II - 6 laning of IT City Chowk to Kurali Chandigarh Road (Design length: 31.23 Km) in the state of Punjab on EPC mode'. The accepted bid price is Rs 726 crore.

FDC has launched oral suspension of Favipiravir to treat mild to moderate cases of COVID-19 in the country. This prescription-only Favenza oral suspension is currently available at all retail medical outlets and hospital pharmacies across India. Convenient loading dosage of the oral suspension helps reduce dosage frequency.

Goa Carbon has resumed the operation at the Company's Paradeep unit located at Vill. Udayabata, Paradeepgarh, Dist. Jagatsinghpur. The Kiln has been lit up from July 12, 2021. After preliminary heat up and commencement of feeding of raw material, normal production is likely to resume shortly.

Abbott has launched COVID-19 home test kit in India for the detection of the SARS-CoV-2 virus in adults and children with or without symptoms at a price of Rs 325 for a single test kit pack. The company will deliver millions of Panbio COVID-19 rapid antigen tests, available for self-use, to ease the burden on healthcare systems in urban and rural India.

JK Tyre & Industries has further expanded its retail presence with the onboarding of digital automotive aftermarket platform Ki Mobility Solutions. The move is expected to help the tyre maker shore up its market share across two-wheelers, passenger cars and commercial vehicle segments.

NMDC has reduced the prices of lump ore and fines by Rs 200 per tonne each. Iron ore is the key raw material for steel making. Any change in its prices has a direct impact on the rates of steel.

Mahindra & Mahindra (M&M) has increased the prices of a..
12Jul07-12-2021$Abbott launches COVID-19 home test kit in India Abbott launches COVID-19 hom

Abbott has launched COVID-19 home test kit in India for the detection of the SARS-CoV-2 virus in adults and children with or without symptoms at a price of Rs 325 for a single test kit pack.

The company will deliver millions of Panbio COVID-19 rapid antigen tests, available for self-use, to ease the burden on healthcare systems in urban and rural India.

Abbott India is healthcare company that discovers, develops, manufactures and markets innovative products and services.

Abbott has launched COVID-19 home test kit in India for the det..
03Jul07-03-2021$Abbott India informs about newspaper advertisement Abbott India informs about n

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, Abbott India has informed that it has enclosed the Public Notice, informing about the Seventy-seventh Annual General Meeting of the Company along with the details of the remote e-voting facility and e-voting at the Annual General Meeting, Book Closure dates and Dividend, published in the Business Standard (All Editions) and Loksatta on Saturday, July 3, 2021.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30 of the Securities and Exchange Board..
29Jun06-29-2021$Abbott India informs about analyst meet Abbott India informs about a
With reference to earlier letter dated June 24, 2021 regarding the Institutional Shareholders/ Analysts Meet, Abbott India has informed that the complete recording of the Meeting is available on the website of the Company at www.abbott.co.in. Further, the transcript of the same shall be uploaded on the website of the Company in due 
course.

The above information is a part of company’s filings submitted to BSE.

With reference to earlier letter dated June 24, 2021 regarding..
Financials More
Rs. in Millions
QTR Mar 21 ANNUAL 21
Net Profit1524.76906.9
Gross Profit 2018.8 9259.5
Operating Profit 2217.310023.6
Net Sales 10955.443100.2
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Sanofi India (BSE)
 8367.90 (3.43%)
M.Cap ( in Cr)
19271.79
Alkem Laboratories (BSE)
 3454.55 (3.70%)
M.Cap ( in Cr)
41304.33
Sun Pharma Inds. (BSE)
 774.00 (10.06%)
M.Cap ( in Cr)
185708.53
Divi's Lab (BSE)
 4904.65 (1.20%)
M.Cap ( in Cr)
130203.05
Dr. Reddy's Lab (BSE)
 4712.70 (0.89%)
M.Cap ( in Cr)
78400.54
Shareholding Pattern More
PROMOTERS 74.99 %
MUTUAL FUNDS/UTI 3.42 %
FI/BANKS/INSURANCE 2.38 %
NON-INSTITUTION 18.03 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes